Selected article for: "control group and meplazumab group"
Author: Huijie Bian; Zhao-Hui Zheng; Ding Wei; Zheng Zhang; Wen-Zhen Kang; Chun-Qiu Hao; Ke Dong; Wen Kang; Jie-Lai Xia; Jin-Lin Miao; Rong-Hua Xie; Bin Wang; Xiu-Xuan Sun; Xiang-Min Yang; Peng Lin; Jie-Jie Geng; Ke Wang; Hong-Yong Cui; Kui Zhang; Xiao-Chun Chen; Hao Tang; Hong Du; Na Yao; Shuang-Shuang Liu; Lin-Na Liu; Zhe Zhang; Zhao-Wei Gao; Gang Nan; Qing-Yi Wang; Jian-Qi Lian; Zhi-Nan Chen; Ping Zhu
Title: Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
  • Document date: 2020_3_24
    • ID: 6g34qwer_24
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.21.20040691 doi: medRxiv preprint antiviral treatment, glucocorticoid treatment, and antibiotic treatment. 4 common cases, 6 severe cases, and 7 critical cases were enrolled in meplazumab group. In contrast, 4 common cases, 4 severe cases, and 3 critical cases were collected in control group, showing no difference compared to meplazumab group.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.21.20040691 doi: medRxiv preprint antiviral treatment, glucocorticoid treatment, and antibiotic treatment. 4 common cases, 6 severe cases, and 7 critical cases were enrolled in meplazumab group. In contrast, 4 common cases, 4 severe cases, and 3 critical cases were collected in control group, showing no difference compared to meplazumab group (p=0.688). Subsequently, 11 patients had received 3 doses meplazumab, and 6 patients had received 2 doses meplazumab.

    Search related documents:
    Co phrase search for related documents
    • antibiotic treatment and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • antibiotic treatment and glucocorticoid treatment: 1, 2, 3, 4, 5, 6
    • antibiotic treatment and severe case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibiotic treatment glucocorticoid treatment and glucocorticoid treatment: 1
    • antiviral treatment and common case: 1, 2
    • antiviral treatment and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral treatment and critical case: 1, 2, 3
    • antiviral treatment and difference show: 1
    • antiviral treatment and glucocorticoid treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral treatment and severe case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • common case and control group: 1, 2, 3, 4
    • common case and critical case: 1, 2, 3, 4, 5, 6, 7, 8
    • common case and meplazumab group: 1
    • common case and severe case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • control group and critical case: 1, 2, 3, 4
    • control group and difference show: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • control group and glucocorticoid treatment: 1, 2
    • control group and meplazumab group: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • control group and severe case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18